Pharmaceutical preparations (e.g., capsules, liniments, ointments, tablets) manufacturing · California
Fujifilm Diosynth Biotechnologies California
Thousand Oaks, CA · ~195 workers · 3 years of OSHA Injury Tracking Application data.
- A
- Excellent Safety Record
- 0.7
- Avg TCR
- 3.3
- Industry avg
- 0
- Fatalities
The verdict
Fujifilm Diosynth Biotechnologies California runs at 21% of its industry's injury rate - far safer than the typical Pharmaceutical preparations (e.g., capsules, liniments, ointments, tablets) manufacturing workplace, earning a grade A.
Fujifilm Diosynth Biotechnologies California: 0.7 TCR = 21% of Pharmaceutical preparations (e.g., capsules, liniments, ointments, tablets) manufacturing BLS 3.3 · 3y Form 300A (see methodology below)
Fujifilm Diosynth Biotechnologies California safety composite
Fujifilm Diosynth Biotechnologies California scores strongest on dart rate (safer than 83% of same-industry peers) and weakest on fatalities (safer than 50%), blended into one 0-100 breakdown against same-industry peers. A missing measure drops out and redistributes its weight rather than deflating the score. This is a per-dimension breakdown, distinct from the single letter grade above it (which weights TCR alone against the BLS industry benchmark).
74/100
Percentile-weighted across 3 of 3 measures
- Total Case Rate (TCR)
- B 0.68 per 100 workers
Safer than 80% of industry peers
- DART rate
- B 0 per 100 workers
Safer than 83% of industry peers
- Fatalities
- D 0
Safer than 50% of industry peers
Benchmarked live against every credibly-rated employer in the same NAICS industry code in the current OSHA extract (a segment must have at least 8 rated peers to benchmark). Not a legal or compliance determination; PlainSafetyScore's own weighting (TCR 40%, DART 35%, fatalities 25%).
TCR Δ
−0.9
2022→2024
Fujifilm Diosynth Biotechnologies California injury rate improved
Fujifilm Diosynth Biotechnologies California's TCR fell 0.9 from 0.9 in 2022 to 0.0 in 2024. Peak filing year was 2023 at 1.1 TCR. In 2024, DART was 0× this establishment's average TCR (severity share of cases).
2022=0.9 · 2023=1.1 · 2024=0.0
OSHA ITA Form 300A scorecard
Establishment book 325412 · Thousand Oaks, CA AT/BELOW-IND · MID
Grade A · TCR 0.7 · 21% of ind
- DART 0.0 DART
- RANK #8/79
- PHOTO Corium Innovations, …
- BOOK 3y book
- INJ 2 inj
- SIZE ~195 FTE
Nearest TCR peer: Corium Innovations, Inc. (0.0 TCR gap)
Read with this employer → · Industry book → · California employers → · Look up another →
Fujifilm Diosynth Biotechnologies California in the TCR neighbourhood
Average Total Case Rate among this establishment and nearest same-industry peers
- This site
Fujifilm Diosynth Biotechnologies California
0.7 TCR
- Corium Innovat
Corium Innovations, Inc.
0.7 TCR
- Natrol Industr
Natrol Industries LLC
0.7 TCR
- Dendreon Pharm
Dendreon Pharmaceuticals LLC
0.7 TCR
- Quotient Scien
Quotient Sciences - Philadelphia, LLC
0.7 TCR
What this shows Fujifilm Diosynth Biotechnologies California averages 0.7 TCR (21% of the Pharmaceutical preparations (e.g., capsules, liniments, ointments, tablets) manufacturing BLS benchmark).
Fujifilm Diosynth Biotechnologies California TCR series: 2022=0.9 · 2023=1.1 · 2024=0 · BLS 3.3
Where Fujifilm Diosynth Biotechnologies California falls in its industry
855 Pharmaceutical preparations (e establishmentsSafer than 80% of graded establishments in this industry, whose median TCR is 1.6.
Narrower to California alone (the establishments it most directly competes with for workers and contracts): ranked #8 safest of 79 Pharmaceutical preparations (e employers in California.
Fujifilm Diosynth Biotechnologies California has more employees than the Pharmaceutical preparations (e.g., capsu median and a lower injury rate than the industry's median TCR of 1.6. Workforce size and injury rate do not always move together within the same industry -- some of its smaller peers run higher rates than its larger ones, and vice versa.
Year-by-Year Safety Data
| Year | TCR | DART | Injuries | Illnesses | Fatalities |
|---|---|---|---|---|---|
| 2024 | 0.0 | 0.0 | 0 | 0 | 0 |
| 2023 | 1.1 | 0.5 | 2 | 0 | 0 |
| 2022 | 0.9 | 0.9 | 0 | 1 | 0 |
OSHA ITA peer cross-reference
Establishment peer ledger
325412 · CA · Thousand Oaks
855 Pharmaceutical preparations (e.g., capsules, liniments, ointments, tablets) manufacturing employers nationwide with a credible TCR · 51,834 rated employers in California with headcount on file · 143 employers in Thousand Oaks, CA · 4 cross-state NAT-TCR peers · 4 cross-state NAT-SIZE peers. Closest matches by relationship code are listed below.
| Rel | Establishment | Metric |
|---|---|---|
| NAICS-TCR | Corium Innovations, Inc. | 0.7 TCR |
| NAICS-TCR | Natrol Industries LLC | 0.7 TCR |
| NAICS-TCR | Dendreon Pharmaceuticals LLC | 0.7 TCR |
| NAICS-TCR | Quotient Sciences - Philadelphia, LLC | 0.7 TCR |
| STATE-SIZE | TekWorks, Inc | 195 FTE |
| STATE-SIZE | 730-PL001 | 195 FTE |
| STATE-SIZE | OXNARD CA PLANT (BBL) | 195 FTE |
| STATE-SIZE | SPI-Anderson Sawmill | 195 FTE |
| CITY-NEAR | Amgen Inc. (Thousand Oaks, CA) | 5,792 FTE |
| CITY-NEAR | Amgen USA (Sales - Flex workers) | 2,803 FTE |
| CITY-NEAR | California Department of Transportation Facility 472 | 2,621 FTE |
| CITY-NEAR | Los Robles Hospital and Medical Center | 1,651 FTE |
| NAT-TCR | Elo Restoration INC | 0.7 TCR |
| NAT-TCR | Oil States Industries Corporate | 0.7 TCR |
| NAT-TCR | RDR Utility Services Group | 0.7 TCR |
| NAT-TCR | Progressive Contracting, Inc. | 0.7 TCR |
| NAT-SIZE | Focus Electric, LLC | 195 FTE |
| NAT-SIZE | Manna Pro Products Omaha | 195 FTE |
| NAT-SIZE | 2558 Aspen Hill | 195 FTE |
| NAT-SIZE | Prisma-Richland Hospital | 195 FTE |
Rel codes: NAICS-TCR · STATE-SIZE · CITY-NEAR · NAT-TCR/NAT-SIZE cross-state. Read with this employer →
Read our methodology - how this data is sourced, computed, and verified.